# Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne

> **NCT03076320** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Guadalajara** · enrollment: 82 (actual)

## Conditions studied

- Acne Vulgaris Superficial Mixed Comedonal and Inflammatory

## Interventions

- **COMBINATION_PRODUCT:** PDF+M-DDO
- **COMBINATION_PRODUCT:** A+PBO

## Key facts

- **NCT ID:** NCT03076320
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2023-07-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03076320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03076320, "Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03076320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*